ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.94695
-0.22%
Brent Oil
83.515
0.47%
Bitcoin
64,435.53
0.68%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Karyopharm Therapeutics Inc (KPTI)

  7. Karyopharm Therapeutics Inc (KPTI) Noticias

KPTI Karyopharm Therapeutics Inc

1.13
0.00 (0.00%)
05 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Karyopharm Therapeutics Inc KPTI NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 1.13 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.13
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202415:30PRNUSKaryopharm to Report First Quarter 2024 Financial Results on..
01/5/202415:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
24/4/202415:01PRNUSKaryopharm Announces Presentations in Endometrial Cancer and..
01/4/202415:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
06/3/202415:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:05PRNUSKaryopharm to Participate at Barclays 26th Annual Global..
04/3/202418:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202418:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202418:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202418:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202418:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
29/2/202416:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202406:43EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202406:35EDGAR2Form 8-K - Current report
29/2/202406:30PRNUSKaryopharm Reports Fourth Quarter and Full Year 2023..
22/2/202406:00PRNUSKaryopharm to Report Fourth Quarter and Full Year 2023..
20/2/202415:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202407:00EDGAR2Form 8-K - Current report
14/2/202409:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202405:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202415:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
25/1/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202418:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202418:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202417:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202417:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202417:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202407:40EDGAR2Form 8-K - Current report
08/1/202407:30PRNUSKaryopharm Announces Preliminary Unaudited 2023 Revenue and..
03/1/202406:00PRNUSKaryopharm to Present at 42nd Annual J.P. Morgan Healthcare..
02/1/202415:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
12/12/202315:05EDGAR2Form 8-K - Current report
10/12/202319:15PRNUSKaryopharm Shares Data at ASH 2023 Showing Strong SVR and..
05/12/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202315:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
08/11/202315:05PRNUSKaryopharm to Participate at Upcoming Investor Conferences
07/11/202316:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202306:00PRNUSKaryopharm Announces New Preliminary Data in Overall..
02/11/202308:20PRNUSKaryopharm Announces Presentations at the 65th American..
02/11/202306:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Su Consulta Reciente

NASDAQ
KPTI
Karyopharm Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados